These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 10097214)

  • 1. Why is mortality rate after percutaneous transluminal coronary angioplasty higher in women?
    Brodie BR
    Am Heart J; 1999 Apr; 137(4 Pt 1):582-4. PubMed ID: 10097214
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical and angiographic correlates of in-hospital death after percutaneous transluminal coronary angioplasty for conditions other than acute myocardial infarction.
    Kahn JK; Rutherford BD; McConahay DR; Johnson WL; Giorgi LV; Ligon RW; Hartzler GO
    Am J Cardiol; 1993 Oct; 72(11):826-7. PubMed ID: 8213518
    [No Abstract]   [Full Text] [Related]  

  • 3. Trends in success rate after percutaneous transluminal coronary angioplasty in men and women with coronary artery disease.
    Hussain KM; Estrada AQ; Kogan A; Dadkhah S; Foschi A
    Am Heart J; 1997 Oct; 134(4):719-27. PubMed ID: 9351740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reasons for higher in-hospital mortality >24 hours after percutaneous transluminal coronary angioplasty in women compared with men.
    Welty FK; Lewis SM; Kowalker W; Shubrooks SJ
    Am J Cardiol; 2001 Sep; 88(5):473-7. PubMed ID: 11524052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cause of in-hospital death in 12,232 consecutive patients undergoing percutaneous transluminal coronary angioplasty. The Northern New England Cardiovascular Disease Study Group.
    Malenka DJ; O'Rourke D; Miller MA; Hearne MJ; Shubrooks S; Kellett MA; Robb JF; O'Meara JR; VerLee P; Bradley WA; Wennberg D; Ryan T; Vaitkus PT; Hettleman B; Watkins MW; McGrath PD; O'Connor GT
    Am Heart J; 1999 Apr; 137(4 Pt 1):632-8. PubMed ID: 10223894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The need for "compassionate provider profiling": refining risk assessment for percutaneous coronary intervention.
    Peterson ED
    J Am Coll Cardiol; 2011 Feb; 57(8):912-3. PubMed ID: 21329836
    [No Abstract]   [Full Text] [Related]  

  • 7. Survival after percutaneous transluminal coronary angioplasty in patients with severe left ventricular dysfunction.
    Maiello L; Colombo A; Gianrossi R; Almagor Y; Finci L
    Chest; 1994 Mar; 105(3):733-40. PubMed ID: 8131534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Guidelines for percutaneous transluminal coronary angioplasty. A report of the American Heart Association/American College of Cardiology Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Committee on Percutaneous Transluminal Coronary Angioplasty).
    Ryan TJ; Bauman WB; Kennedy JW; Kereiakes DJ; King SB; McCallister BD; Smith SC; Ullyot DJ
    Circulation; 1993 Dec; 88(6):2987-3007. PubMed ID: 8252713
    [No Abstract]   [Full Text] [Related]  

  • 9. Red blood cell storage duration and mortality in patients undergoing percutaneous coronary intervention (Am Heart J 2010;159:876-81).
    Lu C; Chen YC
    Am Heart J; 2010 Nov; 160(5):e35; author reply e37. PubMed ID: 21095261
    [No Abstract]   [Full Text] [Related]  

  • 10. Documentation of decline in morbidity in women undergoing coronary angioplasty (a report from the 1993-94 NHLBI Percutaneous Transluminal Coronary Angioplasty Registry). National Heart, Lung, and Blood Institute.
    Jacobs AK; Kelsey SF; Yeh W; Holmes DR; Block PC; Cowley MJ; Bourassa MG; Williams DO; King SB; Faxon DP; Myler R; Detre KM
    Am J Cardiol; 1997 Oct; 80(8):979-84. PubMed ID: 9352963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variation in outcomes after percutaneous coronary intervention in the United States and predictors of periprocedural mortality.
    Mukherjee D; Wainess RM; Dimick JB; Cowan JA; Rajagopalan S; Chetcuti S; Grossman PM; Upchurch GR
    Cardiology; 2005; 103(3):143-7. PubMed ID: 15722631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Percutaneous intervention in the very elderly: weighing the risks and benefits.
    Peterson ED; Batchelor WB
    Am Heart J; 1999 Apr; 137(4 Pt 1):585-7. PubMed ID: 10097215
    [No Abstract]   [Full Text] [Related]  

  • 13. Percutaneous transluminal coronary angioplasty in patients aged > or = 90 years.
    Weyrens FJ; Goldenberg I; Mooney JF; Holmes DR; O'Keefe J; Myler RK; Shaw R; Weintraub W; Cowley M; Kern M
    Am J Cardiol; 1994 Aug; 74(4):397-8. PubMed ID: 8059706
    [No Abstract]   [Full Text] [Related]  

  • 14. Restenosis after coronary angioplasty for rapidly progressive coronary stenosis.
    Bauters C; Passart F; Lablanche JM; McFadden EP; Hamon M; Bertrand ME
    Eur Heart J; 1996 Nov; 17(11):1671-7. PubMed ID: 8922915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Percutaneous transluminal coronary angioplasty failures in patients with multivessel disease. Is there an increased risk?
    Wang N; Gundry SR; Van Arsdell G; Razzouk AJ; Hill AC; Sjolander M; Cavazos KA; Brewer JM; Vyhmeister EE; Bailey LL
    J Thorac Cardiovasc Surg; 1995 Jul; 110(1):214-21; discussion 221-3. PubMed ID: 7609545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of target vessel size and body surface area on outcomes after percutaneous coronary interventions in women.
    Cantor WJ; Miller JM; Hellkamp AS; Kramer JM; Peterson ED; Hasselblad V; Zidar JP; Newby LK; Ohman EM
    Am Heart J; 2002 Aug; 144(2):297-302. PubMed ID: 12177648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Percutaneous transluminal coronary angioplasty in the elderly: epidemiology, clinical risk factors, and in-hospital outcomes. The Northern New England Cardiovascular Disease Study Group.
    Wennberg DE; Makenka DJ; Sengupta A; Lucas FL; Vaitkus PT; Quinton H; O'Rourke D; Robb JF; Kellett MA; Shubrooks SJ; Bradley WA; Hearne MJ; Lee PV; O'Connor GT
    Am Heart J; 1999 Apr; 137(4 Pt 1):639-45. PubMed ID: 10223895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coronary angioplasty in diabetic patients. The National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry.
    Kip KE; Faxon DP; Detre KM; Yeh W; Kelsey SF; Currier JW
    Circulation; 1996 Oct; 94(8):1818-25. PubMed ID: 8873655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of acute coronary occlusion during percutaneous transluminal coronary angioplasty: experience of complications in a hospital without on site facilities for cardiac surgery.
    Richardson SG; Morton P; Murtagh JG; O'Keeffe DB; Murphy P; Scott ME
    BMJ; 1990 Feb; 300(6721):355-8. PubMed ID: 2106983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Percutaneous transluminal coronary angioplasty in patients 80 years of age and older.
    Rich JJ; Crispino CM; Saporito JJ; Domat I; Cooper WM
    Am J Cardiol; 1990 Mar; 65(9):675-6. PubMed ID: 2309638
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.